Pharma channel feed

Nestlé parts with peanut al­ler­gy treat­ment Pal­forzia

Last year
Deals

No­var­tis sues over IRA ahead of En­tresto price ne­go­ti­a­tions

Last year
Law

Lung can­cer bio­mark­er cam­paign, launched with As­traZeneca, boosts its reach and adds phar­ma sup­port­ers

Last year
Marketing

Mar­ket­ingRx roundup: No­vavax pro­motes vac­cines on Tik­Tok; BIO read­ies for fall pod­cast sea­son

Last year
Marketing

Bay­er ex­pands Keren­dia heart fail­ure pro­gram to 15,000 pa­tients as it plans to start three Phase III tri­als

Last year
R&D

GSK in­vests $270M in­to vac­cine man­u­fac­tur­ing in Bel­gium

Last year
Manufacturing

FDA of­fers clar­i­ty on post-warn­ing let­ter meet­ings in new draft guid­ance

Last year
FDA+

EMA safe­ty com­mit­tee ramps up warn­ing against use of top­i­ra­mate dur­ing preg­nan­cy

Last year
FDA+

Phar­ma and health­care spend­ing ex­pect­ed to help push ad in­dus­try to first-ever $1T to­tal in 2024, study says

Last year
Marketing

Glob­al threat of an­tibi­ot­ic re­sis­tance high­light­ed in new film sup­port­ed by Pfiz­er, MSD, Sh­iono­gi and AMR Ac­tion Fund

Last year
Marketing

Am­gen and Hori­zon can close their $28B deal af­ter re­solv­ing law­suit by the FTC

Last year
Deals

Le­gal ex­perts say some IRA chal­lenges are 'weak­er than oth­er­s'

Last year
Law

Lil­ly, No­vo, Sanofi face pres­sure from law­mak­ers to clar­i­fy low-cost in­sulin pro­grams

Last year
FDA+

Alvotech re­sub­mits its in­ter­change­able Hu­mi­ra biosim­i­lar as Ab­b­Vie clings to brand dom­i­nance

Last year

Stop TB says the price of J&J's tu­ber­cu­lo­sis treat­ment be­daquiline drops 55%

Last year

Phar­ma in­dus­try rep­u­ta­tion set­tles in­to ‘new nor­mal’ af­ter good­will from in­sulin price drop fades

Last year
Marketing

Mallinck­rodt files for bank­rupt­cy for the sec­ond time, se­cures $150M to con­tin­ue op­er­at­ing

Last year

Sage re­mains tight-lipped on post­par­tum launch plans in wake of re­struc­tur­ing

Last year
People

Alk­er­mes, Te­va set­tle patent suit around opi­oid-block­er Viv­it­rol, paving way for gener­ics af­ter three-year fight

Last year
Law

Sanofi taps se­r­i­al biotech in­vestor, en­tre­pre­neur as R&D chief — while pro­mot­ing busi­ness op­er­a­tions, dig­i­tal lead­ers

Last year
People

Can­cer drugs in US are ‘not af­ford­able,’ says Ger­man study, which sug­gests set­ting drug prices by in­di­ca­tion 

Last year

In­cyte scores soc­cer star Mia Hamm as new spokesper­son to raise aware­ness of graft-ver­sus-host dis­ease

Last year
Marketing

The cost of We­govy: $1.1M to pre­vent one ma­jor car­dio­vas­cu­lar event, Airfin­i­ty says

Last year

Pfiz­er and BioN­Tech 'ready to ship' up­dat­ed Covid-19 vac­cine in EU on heels of CHMP rec­om­men­da­tion

Last year
Coronavirus
First page Previous page 104105106107108109110 Next page Last page
A service from the Financial Times